Summary

The product HGH, submitted by Anabolic Empire, underwent independent testing to verify its composition and purity. The sample, identified by Task Number #47579, was submitted by aempire.support@protonmail.com and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control.

The analysis confirmed the presence of 3.43 mg / 10.29 IU of recombinant human growth hormone (rHGH) per vial, with a purity level of 95.551%. Additionally, no dimer or related proteins were detected. Testing was initiated on 31 July 2024, the sample was received on 19 August 2024, and analysis was completed on 20 August 2024.

While these results indicate a relatively high level of purity, the lack of manufacturer and batch details raises concerns about product consistency. Independent third-party testing across multiple samples remains critical to ensuring product reliability.


Detailed Report

Product Overview

Testing Details

Testing Results


Verification Details


Evaluation of Manufacturer-Submitted Testing

This analysis confirms that the tested HGH sample has a high purity level (95.551%) and no detected impurities. However, as the product’s manufacturer and batch details remain unknown, concerns regarding consistency and reliability persist. Since the sample was submitted by a third party, independent verification through additional testing would enhance credibility and ensure product quality.


Conclusion

The tested HGH sample contains 3.43 mg / 10.29 IU of rHGH with a purity of 95.551%, indicating a good-quality product for this specific sample. However, given the unknown manufacturing details, independent verification remains necessary to ensure consistency across multiple batches.


Disclaimer

This report is provided for educational and harm reduction purposes. Manufacturer-submitted testing may have inherent biases, and results should be interpreted cautiously. Consumers are encouraged to consider multiple independent tests when evaluating product quality.